Updated
Updated · Oncodaily · Aug 10
Andrea Villa Publishes 18-Author Review on AI Augmenting Oncology Clinical Trials
Updated
Updated · Oncodaily · Aug 10

Andrea Villa Publishes 18-Author Review on AI Augmenting Oncology Clinical Trials

2 articles · Updated · Oncodaily · Aug 10

Summary

  • Nature Reviews Clinical Oncology has published an 18-author review examining how AI could augment oncology clinical trials across the full trial lifecycle.
  • The paper outlines uses from trial design and patient recruitment to monitoring, evidence generation and digital twins, framing AI as support for multiple trial stages rather than a single tool.
  • Andrea Villa, an operational board member at Cancer Core Europe, announced the publication on LinkedIn and highlighted contributions from co-authors including Ashley Eadie, Arsela Prelaj and Ravi B. Parikh.
  • The publication adds to growing attention on how AI may reshape cancer research workflows, especially in designing and running clinical studies.

Insights

While AI promises rapid trial screening, could hidden algorithmic biases quietly exclude vulnerable patients from life-saving cancer treatments?
Could AI-driven digital twins eventually replace human patients in control arms, or will regulatory hurdles keep them strictly theoretical?